The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin.

AUTOR(ES)

Patsalos, P N

RESUMO

Denzimol, a new anticonvulsant drug, is currently undergoing clinical evaluation. In this paper we report its use in six patients who were also taking carbamazepine and two patients taking phenytoin. There was a striking elevation of serum carbamazepine, carbamazepine-10, 11 epoxide and phenytoin concentrations in all patients on the addition of denzimol therapy. The interaction with carbamazepine is greater in severity than any other reported to date and denzimol's interaction with both carbamazepine and phenytoin is likely to prove of major clinical significance.

Documentos Relacionados

• Prophylaxis and treatment of posttraumatic epilepsy with phenytoin.
• Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates.
• Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction.
• Carbamazepine, phenytoin, and the fetus
• Bioavailability and dissolution of proprietary and generic formulations of phenytoin.